Suscribirse

How concerns and experiences with medical malpractice affect dermatopathologists' perceptions of their diagnostic practices when interpreting cutaneous melanocytic lesions - 15/01/16

Doi : 10.1016/j.jaad.2015.09.037 
Patricia A. Carney, PhD a, b, ⁎ , Paul D. Frederick, MPH, MBA e, Lisa M. Reisch, PhD e, Stevan Knezevich, MD, PhD g, Michael W. Piepkorn, MD f, h, Raymond L. Barnhill, MD i, j, David E. Elder, MB Chb, FRCPA k, Berta M. Geller, EdD l, Linda Titus, PhD m, Martin A. Weinstock, MD, PhD n, o, p, Heidi D. Nelson, MD, MPH c, d, q, Joann G. Elmore, MD, MPH e
a Department of Family Medicine, Oregon Health and Science University, Portland, Oregon 
b Department of Public Health and Preventive Medicine, Oregon Health and Science University, Portland, Oregon 
c Department of Medical Informatics and Clinical Epidemiology, Oregon Health and Science University, Portland, Oregon 
d Department of Medicine, Oregon Health and Science University, Portland, Oregon 
e Department of Internal Medicine, University of Washington School of Medicine, Seattle, Washington 
f Department of Medicine, University of Washington School of Medicine, Seattle, Washington 
g Pathology Associates, Clovis, California 
h Dermatopathology Northwest, Bellevue, Washington 
i Department of Pathology, University of California, Los Angeles, California 
j Department of Pathology, Institut Curie, Paris, France 
k Pathology, University of Pennsylvania, Philadelphia, Pennsylvania 
l Family Medicine, University of Vermont, Burlington, Vermont 
m Epidemiology and of Pediatrics, Geisel School of Medicine at Dartmouth, Lebanon, New Hampshire 
n Dermatology and Epidemiology, Center for Dermatoepidemiology, Department of Veterans Affairs Medical Center, Providence, Rhode Island 
o Department of Dermatology, Rhode Island Hospital, Providence, Rhode Island 
p Departments of Dermatology and Epidemiology, Brown University, Providence, Rhode Island 
q Cancer Prevention and Screening, Providence Cancer Center, Providence Health and Services Oregon, Portland, Oregon 

∗Reprint requests: Patricia A. Carney, PhD, Department of Family Medicine, Oregon Health and Science University, 3181 SW Sam Jackson Park Rd, Mail Code: FM, Portland, OR 97239.

Abstract

Objective

We sought to identify characteristics associated with past malpractice lawsuits and how malpractice concerns may affect interpretive practices.

Methods

We surveyed 207 of 301 (68.8%) eligible dermatopathologists who interpret melanocytic skin lesions in 10 states. The survey assessed dermatopathologists' demographic and clinical practice characteristics, perceptions of how medical malpractice concerns could influence their interpretive practices, and past malpractice lawsuits.

Results

Of dermatopathologists, 33% reported past malpractice experiences. Factors associated with being sued included older age (57 vs 48 years, P < .001), lack of board certification or fellowship training in dermatopathology (76.5% vs 53.2%, P = .001), and greater number of years interpreting melanocytic lesions (>20 years: 52.9% vs 20.1%, P < .001). Of participants, 64% reported being moderately or extremely confident in their melanocytic interpretations. Although most dermatopathologists believed that malpractice concerns increased their likelihood of ordering specialized pathology tests, obtaining recuts, and seeking a second opinion, none of these practices were associated with past malpractice. Most dermatopathologists reported concerns about potential harms to patients that may result from their assessments of melanocytic lesions.

Limitations

Limitations of this study include lack of validation of and details about the malpractice suits experienced by participating dermatopathologists. In addition, the study assessed perceptions of practice rather than actual practices that might be associated with malpractice incidents.

Conclusions

Most dermatopathologists reported apprehension about how malpractice affects their clinical practice and are concerned about patient safety irrespective of whether they had actually experienced a medical malpractice suit.

El texto completo de este artículo está disponible en PDF.

Key words : additional histology testing, clinical interpretation, defensive clinical practice, dermatopathology, medical malpractice, melanoma


Esquema


 Supported by the National Cancer Institute (R01 CA151306). The content is solely the responsibility of the authors and does not necessarily represent the views of the National Cancer Institute or the National Institutes of Health.
 Survey available at www.jaad.org.
 Conflicts of interest: None declared.


© 2015  American Academy of Dermatology, Inc.. Publicado por Elsevier Masson SAS. Todos los derechos reservados.
Añadir a mi biblioteca Eliminar de mi biblioteca Imprimir
Exportación

    Exportación citas

  • Fichero

  • Contenido

Vol 74 - N° 2

P. 317 - février 2016 Regresar al número
Artículo precedente Artículo precedente
  • Association of health insurance with outcomes in adults ages 18 to 64 years with melanoma in the United States
  • Arya Amini, Chad G. Rusthoven, Timothy V. Waxweiler, Bernard L. Jones, Christine M. Fisher, Sana D. Karam, David Raben
| Artículo siguiente Artículo siguiente
  • Multiple primary melanomas (MPMs) and criteria for genetic assessment: MultiMEL, a multicenter study of the Italian Melanoma Intergroup
  • William Bruno, Lorenza Pastorino, Paola Ghiorzo, Virginia Andreotti, Claudia Martinuzzi, Chiara Menin, Lisa Elefanti, Camilla Stagni, Antonella Vecchiato, Monica Rodolfo, Andrea Maurichi, Siranoush Manoukian, Vincenzo De Giorgi, Imma Savarese, Francesca Gensini, Lorenzo Borgognoni, Alessandro Testori, Giuseppe Spadola, Mario Mandalà, Gianlorenzo Imberti, Paola Savoia, Chiara Astrua, Anna Maria Ronco, Alessandra Farnetti, Maria Grazia Tibiletti, Maurizio Lombardo, Giuseppe Palmieri, Fabrizio Ayala, Paolo Ascierto, Giovanni Ghigliotti, Marisa Muggianu, Francesco Spagnolo, Virginia Picasso, Enrica Teresa Tanda, Paola Queirolo, Giovanna Bianchi-Scarrà

Bienvenido a EM-consulte, la referencia de los profesionales de la salud.
El acceso al texto completo de este artículo requiere una suscripción.

¿Ya suscrito a @@106933@@ revista ?

@@150455@@ Voir plus

Mi cuenta


Declaración CNIL

EM-CONSULTE.COM se declara a la CNIL, la declaración N º 1286925.

En virtud de la Ley N º 78-17 del 6 de enero de 1978, relativa a las computadoras, archivos y libertades, usted tiene el derecho de oposición (art.26 de la ley), el acceso (art.34 a 38 Ley), y correcta (artículo 36 de la ley) los datos que le conciernen. Por lo tanto, usted puede pedir que se corrija, complementado, clarificado, actualizado o suprimido información sobre usted que son inexactos, incompletos, engañosos, obsoletos o cuya recogida o de conservación o uso está prohibido.
La información personal sobre los visitantes de nuestro sitio, incluyendo su identidad, son confidenciales.
El jefe del sitio en el honor se compromete a respetar la confidencialidad de los requisitos legales aplicables en Francia y no de revelar dicha información a terceros.


Todo el contenido en este sitio: Copyright © 2026 Elsevier, sus licenciantes y colaboradores. Se reservan todos los derechos, incluidos los de minería de texto y datos, entrenamiento de IA y tecnologías similares. Para todo el contenido de acceso abierto, se aplican los términos de licencia de Creative Commons.